Current Report Filing (8-k)
August 29 2022 - 4:17PM
Edgar (US Regulatory)
0001038074
false
0001038074
2022-08-29
2022-08-29
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported):
August 29, 2022
SILICON LABORATORIES INC.
(Exact Name of Registrant as Specified in
Charter)
Delaware |
|
000-29823 |
|
74-2793174 |
(State or Other Jurisdiction |
|
(Commission File Number) |
|
(IRS Employer |
of Incorporation) |
|
|
|
Identification No.) |
|
|
400 West Cesar Chavez, Austin, TX |
|
78701 |
|
|
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrants telephone number, including
area code: (512) 416-8500
Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
¨ Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of
the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
Common Stock, $0.0001 par value |
|
SLAB |
|
The NASDAQ Stock Market LLC |
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth
company ¨
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with
any new or revised financial accounting standards provided pursuant to Section 13(a) of the Securities Exchange Act of
1934. ¨
Item 8.01. Other Events
On August 29, 2022, the Board of Directors of Silicon Laboratories
Inc. (“Silicon Laboratories”) increased the authorization amount of its share repurchase program to $450 million of Silicon
Laboratories common stock through December 2023 (representing a $200 million increase over the $250 million previously authorized). The
program allows for repurchases to be made in the open market or in private transactions, including structured or accelerated transactions,
subject to applicable legal requirements and market conditions. A copy of the press release is attached as Exhibit 99 to this report.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits.
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
SILICON LABORATORIES INC.
|
August 29, 2022 |
|
/s/ John C. Hollister |
Date |
|
John
C. Hollister
Senior Vice
President and
Chief Financial Officer
(Principal Financial Officer)
|
Silicon Labs (NASDAQ:SLAB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Silicon Labs (NASDAQ:SLAB)
Historical Stock Chart
From Apr 2023 to Apr 2024